Abstract
Since the first pancreas transplant nearly 58 years ago, there have been significant improvements in both perioperative and long-term outcomes. Regardless, pancreas transplantation remains a particularly complex procedure with high complication risks [1]. As such, pancreas transplant remains primarily reserved for patients with severe diabetic complications, such as hypoglycemia unawareness. Further, it is the sole treatment that achieves euglycemia and insulin independence for patients with type 1 diabetes.